<DOC>
	<DOCNO>NCT01696617</DOCNO>
	<brief_summary>The investigator hypothesize combined pharmacotherapy use adjunctive aripiprazole standard antidepressant would associate improved depression response Major depressive disorder , especially Quality life . The investigator compare mean change quality life add-on 8 week treatment aripiprazole add-on 6 week treatment aripiprazole .</brief_summary>
	<brief_title>Aripiprazole ( Abilify® ) Adjunctive Treatment Inadequate Response Major Depressive Disorder</brief_title>
	<detailed_description>Previous study quality life measurement patient depression report quality life measure irrespective severity depression quality life aspect depression.The investigator design 6-week single blind study flexible dose aripiprazole augmentation , range 2.5mg maximum 20 mg ( 15mg patient fluoxetine paroxetine ) , patient respond inadequately ( score &gt; 18 MADRS ) first-line antidepressant pharmacotherapy . The investigator compare mean change quality life 8 week .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Age : 1865 Patients major depressive disorder accord DSMIV criterion last &gt; 8 week MADRS total score 18 high Patients respond inadequately ( score &gt; 18 MADRS ) firstline antidepressant treatment 4 week duration Current use standard antidepressant treatment monotherapy combination 2 antidepressant : escitalopram ( 10 20mg/d ) , fluoxetine ( 20 40mg/d ) , paroxetine CR ( 25 50mg/d ) , sertraline ( 100 150mg/d ) , mirtazapine ( 15 45mg/d ) , duloxetine ( 30 60mg/d ) venlafaxine ER ( 150225mg/d ) Past history hypersensitivity aripiprazole Primary diagnosis MDD psychotic feature , bipolar disorder , schizophrenia , schizoaffective disorder , psychotic disorder anxiety disorder , history alcohol/ drug abuse within past 12 month , diagnosis dementia Clinically significant current Axis II ( DSMIVTR ) diagnosis A significant risk suicide corroborate score ≥5 item 10 ( suicidal thought ) MADRS scale clinical judgment investigator Pregnancy breastfeed Presence serious medical illness include cardiac , hepatic , renal , respiratory , endocrinologic , neurologic , hematologic disease physical disorder judge significantly affect central nervous system function Patients take antipsychotic , mood stabilizer psychotropic medication besides antidepressant , except benzodiazepine beta blocker hypnotic Patients past treatment failure aripiprazole</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>